27861771|t|High-density lipoprotein -associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia
27861771|a|Patients with heterozygous familial hypercholesterolaemia (FH) suffer from high plasma cholesterol and an environment of increased oxidative stress. We examined its potential effects on high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) content (HDL - S1P) and HDL -mediated protection against oxidative stress, both with and without statin treatment. In a case-control study, HDL was isolated from 12 FH patients with and without statin treatment and from 12 healthy controls. The HDL - S1P content and the capacity of HDL to protect cardiomyocytes against oxidative stress in vitro were measured. HDL -associated S1P was significantly correlated with cell protection, but not with HDL-cholesterol or apolipoprotein AI. The latter did not correlate with HDL -mediated cell protection. Neither the HDL - S1P content nor HDL protective capacity differed between nontreated FH patients and controls. The relative amounts of apolipoprotein AI and apolipoprotein M were similar between controls and FH patients. Statin treatment had no effect on any of these measures. The FH environment is not detrimental to HDL - S1P content or HDL - S1P -mediated cell protection. Statin treatment does not modulate HDL function in this regard.
27861771	0	24	High-density lipoprotein	T103	UMLS:C0023821
27861771	37	60	sphingosine-1-phosphate	T103	UMLS:C0074992
27861771	73	116	heterozygous familial hypercholesterolaemia	T038	UMLS:C0342882
27861771	131	174	heterozygous familial hypercholesterolaemia	T038	UMLS:C0342882
27861771	176	178	FH	T038	UMLS:C0342882
27861771	180	186	suffer	T033	UMLS:C0751408
27861771	192	215	high plasma cholesterol	T033	UMLS:C0858226
27861771	223	234	environment	T082	UMLS:C0014406
27861771	248	264	oxidative stress	T038	UMLS:C0242606
27861771	303	327	high-density lipoprotein	T103	UMLS:C0023821
27861771	329	332	HDL	T103	UMLS:C0023821
27861771	345	368	sphingosine-1-phosphate	T103	UMLS:C0074992
27861771	370	373	S1P	T103	UMLS:C0074992
27861771	384	387	HDL	T103	UMLS:C0023821
27861771	390	393	S1P	T103	UMLS:C0074992
27861771	399	402	HDL	T103	UMLS:C0023821
27861771	413	448	protection against oxidative stress	T038	UMLS:C3823580
27861771	495	513	case-control study	T062	UMLS:C0007328
27861771	515	518	HDL	T103	UMLS:C0023821
27861771	540	542	FH	T038	UMLS:C0342882
27861771	620	623	HDL	T103	UMLS:C0023821
27861771	626	629	S1P	T103	UMLS:C0074992
27861771	658	661	HDL	T103	UMLS:C0023821
27861771	673	687	cardiomyocytes	T017	UMLS:C0225828
27861771	696	712	oxidative stress	T038	UMLS:C0242606
27861771	737	740	HDL	T103	UMLS:C0023821
27861771	753	756	S1P	T103	UMLS:C0074992
27861771	791	806	cell protection	T038	UMLS:C0524828
27861771	821	836	HDL-cholesterol	T103	UMLS:C0023822
27861771	840	857	apolipoprotein AI	T103	UMLS:C0085201
27861771	893	896	HDL	T103	UMLS:C0023821
27861771	907	922	cell protection	T038	UMLS:C0524828
27861771	936	939	HDL	T103	UMLS:C0023821
27861771	942	945	S1P	T103	UMLS:C0074992
27861771	958	961	HDL	T103	UMLS:C0023821
27861771	1010	1012	FH	T038	UMLS:C0342882
27861771	1060	1077	apolipoprotein AI	T103	UMLS:C0085201
27861771	1082	1098	apolipoprotein M	T103	UMLS:C1438565
27861771	1133	1135	FH	T038	UMLS:C0342882
27861771	1207	1209	FH	T038	UMLS:C0342882
27861771	1210	1221	environment	T082	UMLS:C0014406
27861771	1244	1247	HDL	T103	UMLS:C0023821
27861771	1250	1253	S1P	T103	UMLS:C0074992
27861771	1265	1268	HDL	T103	UMLS:C0023821
27861771	1271	1274	S1P	T103	UMLS:C0074992
27861771	1285	1300	cell protection	T038	UMLS:C0524828
27861771	1337	1340	HDL	T103	UMLS:C0023821